Bosutinib Spirig HC 100 mg

Bosutinib Spirig HC 100 mg is a medicine authorised by Swissmedic under authorisation number 69464. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 22 January 2025 and the authorisation is limited until 21 January 2030. ATC code L01EA04 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 69464
  • ATC L01EA04
  • Synthetic medicines
Authorisation data
Authorisation number69464
NameBosutinib Spirig HC 100 mg
Full nameBosutinib Spirig HC 100 mg, Filmtabletten
Authorisation holderSpirig HealthCare AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01EA04
First authorisation22 January 2025
Authorisation validity21 January 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Bosutinib Spirig HC 100 mg, FilmtablettenA22 January 2025
2Bosutinib Spirig HC 400 mg, FilmtablettenA22 January 2025
3Bosutinib Spirig HC 500 mg, FilmtablettenA22 January 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Tablette(n)L01EA0407.16.1.A
228Tablette(n)L01EA0407.16.1.A
328Tablette(n)L01EA0407.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Bosutinib Spirig HC 100 mg authorised in Switzerland?

Yes. Bosutinib Spirig HC 100 mg is authorised by Swissmedic under authorisation number 69464, data as of 01 September 2026. The authorisation is limited until 21 January 2030.

Which dispensing category does Bosutinib Spirig HC 100 mg have?

Bosutinib Spirig HC 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Bosutinib Spirig HC 100 mg?

The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com